Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1219 | 1036 | 1299 | 1362 | 1824 | 3398 |
Fund Return | 21.94% | 3.59% | 29.9% | 10.84% | 12.77% | 13.01% |
Place in category | 354 | 387 | 666 | 83 | 134 | 16 |
% in Category | 21 | 25 | 41 | 6 | 12 | 4 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Mackenzie Global Dividend Fund AR | 6.94B | 19.35 | 8.04 | 10.16 | ||
Mackenzie Global Dividend Fund F8 | 6.94B | 20.88 | 9.70 | 11.74 | ||
Mackenzie Global Dividend Fund T6 | 6.94B | 19.39 | 8.09 | 10.23 | ||
Mackenzie Global Dividend Fund T8 | 6.94B | 19.42 | 8.12 | 10.23 | ||
Mackenzie Global Div Fund A CAD | 6.94B | 19.38 | 8.08 | 10.21 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 14.78B | 43.16 | 12.27 | - | ||
Mawer Global Equity | 13.79B | 8.62 | 5.37 | 10.93 | ||
Capital Group Glbal Equity Fd F CAD | 13.61B | 22.86 | 3.88 | 11.66 | ||
Capital Group Glbal Equity Fd A CAD | 13.61B | 21.74 | 2.74 | 10.43 | ||
Capital Group Glbal Equity Fd D CAD | 13.61B | 22.55 | 3.53 | 11.18 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 4.41 | 416.97 | +0.29% | |
Apple | US0378331005 | 4.06 | 229.60 | +0.69% | |
JPMorgan | US46625H1005 | 2.86 | 244.50 | -0.22% | |
Amazon.com | US0231351067 | 2.51 | 204.33 | +1.30% | |
AbbVie | US00287Y1091 | 2.34 | 166.30 | +0.01% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Neutral | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review